Liver Cirrhosis - Blood
Research News and Information

Monday, November 23, 2009

Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies.

29 Sep 2009 We have made striking progress in our understanding of the biochemistry and cell biology that underlies liver fibrosis and cirrhosis, including the development of strategies and agents to prevent and reverse fibrosis. However, translation of this ... Read more...

Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6.

29 Sep 2009 More than 750 million people are at risk of infection with foodborne liver flukes. Opisthorchis viverrini is considered among the most important of these parasites, due to its strong association with cholangiocarcinoma (CCA). O. viverrini infection ... Read more...

Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.

12 Sep 2009 Ang-(1-7) (angiotensin-1-7), a peptide product of the recently described ACE (angiotensin-converting enzyme) homologue ACE2, opposes the harmful actions of AngII (angiotensin II) in cardiovascular tissues, but its role in liver disease is unknown. ... Read more...

Latest indexed articles for 'Liver Cirrhosis - Blood'

These are the very latest articles for this heading:

• Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. 29 Sep 2009
• Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6. 29 Sep 2009
• Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. 12 Sep 2009
• Anti-hepatitis B virus X protein in sera is one of the markers of development of liver cirrhosis and liver cancer mediated by HBV. 4 Sep 2009
• Blood hyaluronic acid as a marker for canine cirrhosis. 30 Aug 2009
• Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation. 13 Aug 2009
• The role of nitric oxide and ferritin in the pathogenesis of alcoholic liver disease: a controlled clinical study. 30 Jul 2009
• Successful transcatheter chemoembolization for acute jaundice in a patient with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a case report. 30 Jul 2009
• Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (Review). 30 Jul 2009
• Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist? 29 Jun 2009
• Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma. 29 Jun 2009
• Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis. 29 Jun 2009
• Preoperative evaluation of patients with liver cirrhosis undergoing open heart surgery. 15 Jun 2009
• Observations on cryoglobulin testing: II. The association of oligoclonal mixed cryoglobulinemia with cirrhosis in patients infected with hepatitis C virus. 14 Jun 2009
• A complex role of activin A in non-alcoholic fatty liver disease. 14 Jun 2009
• The association between the serum sodium level and the severity of complications in liver cirrhosis. 6 Jun 2009
• Abnormal hematological indices in cirrhosis. 30 May 2009
• Hemostasis and coagulation monitoring and management during liver transplantation. 30 May 2009
• Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis. 30 May 2009
• Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. 30 May 2009

See a longer list of these articles.

Technical information about 'Liver Cirrhosis'

Definition: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Descriptor UI: D008103

Alternative terms: Liver Cirrhosis; Hepatic Cirrhosis; Cirrhoses, Hepatic; Cirrhosis, Hepatic; Hepatic Cirrhoses; Cirrhosis, Liver; Cirrhoses, Liver; Liver Cirrhoses; Fibrosis, Liver; Fibroses, Liver; Liver Fibroses; Liver Fibrosis;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C06.552.630;

Online Note: use LIVER CIRRHOSIS to search LIVER CIRRHOSIS, POSTNECROTIC 1966-77

History Note: LIVER CIRRHOSIS, POSTNECROTIC was heading 1963-77